APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Melatonin

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.

Selected research

Market Outlook & Growth Opportunities

Global Melatonin Market Outlook and Growth Opportunities 2026

21 December 2025197 pages

Choose your research edition.

Industry ResearchMelatonin Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Melatonin Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Melatonin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Melatonin Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Melatonin Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Melatonin, also known as N-acetyl-5-methoxy tryptamine, is a hormone that is produced by the pineal gland in animals and regulates sleep and wakefulness. Melatonin is also produced in plants where it functions as a first line of defense against oxidative stress.

Neurim Pharma, Natrol, Pharmavite, Nature's Bounty and Jameison are the leaders of the Melatonin industry, which take about 30% market share. North America and Europe are the major region of the global market, which takes about 70% market share.

This report provides an overview of the global Melatonin market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Melatonin and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Melatonin revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Melatonin market.

Melatonin Segment by Company

Natrol

Pharmavite

Nature's Bounty

Jameison

Rexall Sundown

GNC

Xiu Zheng

Church & Dwight

By-Health

Pfizer

Solgar

Biotics Research

Now Food

Melatonin Segment by Type

Pharmaceutical Grade Melatonin

Food Grade Melatonin

Melatonin Segment by Application

Dietary Supplements

Medical

Others

Melatonin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Melatonin status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Melatonin key companies, revenue, market share, and recent developments.

3. To split the Melatonin breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Melatonin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Melatonin significant trends, drivers, influence factors in global and regions.

6. To analyze Melatonin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Melatonin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Melatonin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Melatonin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Melatonin industry.

Chapter 3: Detailed analysis of Melatonin company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Melatonin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Melatonin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Melatonin Industry Trends Table 2. Melatonin Industry Drivers Table 3. Melatonin Industry Opportunities and Challenges Table 4. Melatonin Industry Restraints Table 5. Global Melatonin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Melatonin Revenue Share by Company (2021-2026) Table 7. Global Melatonin Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Melatonin Key Company Manufacturing Base & Headquarters Table 9. Global Melatonin Company, Product Type & Application Table 10. Global Melatonin Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Melatonin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Pharmaceutical Grade Melatonin Table 15. Significant Companies of Food Grade Melatonin Table 16. Global Melatonin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Melatonin Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Melatonin Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Melatonin Sales Value Share by Type (2021-2026) Table 20. Global Melatonin Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Dietary Supplements Table 22. Significant Companies of Medical Table 23. Significant Companies of Others Table 24. Global Melatonin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Melatonin Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Melatonin Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Melatonin Sales Value Share by Application (2021-2026) Table 28. Global Melatonin Sales Value Share by Application (2027-2032) Table 29. Global Melatonin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Melatonin Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Melatonin Sales Value Share by Region (2021-2026) Table 32. Global Melatonin Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Melatonin Sales Value Share by Region (2027-2032) Table 34. Global Melatonin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Melatonin Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Melatonin Sales Value Market Share by Country (2021-2026) Table 37. Global Melatonin Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Melatonin Sales Value Market Share by Country (2027-2032) Table 39. Natrol Company Information Table 40. Natrol Business Overview Table 41. Natrol Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Natrol Melatonin Product Portfolio Table 43. Natrol Recent Development Table 44. Pharmavite Company Information Table 45. Pharmavite Business Overview Table 46. Pharmavite Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Pharmavite Melatonin Product Portfolio Table 48. Pharmavite Recent Development Table 49. Nature's Bounty Company Information Table 50. Nature's Bounty Business Overview Table 51. Nature's Bounty Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Nature's Bounty Melatonin Product Portfolio Table 53. Nature's Bounty Recent Development Table 54. Jameison Company Information Table 55. Jameison Business Overview Table 56. Jameison Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Jameison Melatonin Product Portfolio Table 58. Jameison Recent Development Table 59. Rexall Sundown Company Information Table 60. Rexall Sundown Business Overview Table 61. Rexall Sundown Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Rexall Sundown Melatonin Product Portfolio Table 63. Rexall Sundown Recent Development Table 64. GNC Company Information Table 65. GNC Business Overview Table 66. GNC Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GNC Melatonin Product Portfolio Table 68. GNC Recent Development Table 69. Xiu Zheng Company Information Table 70. Xiu Zheng Business Overview Table 71. Xiu Zheng Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Xiu Zheng Melatonin Product Portfolio Table 73. Xiu Zheng Recent Development Table 74. Church & Dwight Company Information Table 75. Church & Dwight Business Overview Table 76. Church & Dwight Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Church & Dwight Melatonin Product Portfolio Table 78. Church & Dwight Recent Development Table 79. By-Health Company Information Table 80. By-Health Business Overview Table 81. By-Health Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. By-Health Melatonin Product Portfolio Table 83. By-Health Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Melatonin Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Melatonin Product Portfolio Table 88. Pfizer Recent Development Table 89. Solgar Company Information Table 90. Solgar Business Overview Table 91. Solgar Melatonin Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Solgar Melatonin Product Portfolio Table 93. Solgar Recent Development Table 94. Biotics Research Company Information Table 95. Biotics Research Business Overview Table 96. Biotics Research Melatonin Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Biotics Research Melatonin Product Portfolio Table 98. Biotics Research Recent Development Table 99. Now Food Company Information Table 100. Now Food Business Overview Table 101. Now Food Melatonin Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. Now Food Melatonin Product Portfolio Table 103. Now Food Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Melatonin Product Image Figure 2. Global Melatonin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Melatonin Market Size (2021-2032) & (US$ Million) Figure 4. Global Melatonin Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Pharmaceutical Grade Melatonin Image Figure 8. Food Grade Melatonin Image Figure 9. Global Melatonin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Melatonin Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Melatonin Sales Value Share by Type (2021-2032) Figure 12. Dietary Supplements Image Figure 13. Medical Image Figure 14. Others Image Figure 15. Global Melatonin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Melatonin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Melatonin Sales Value Share by Application (2021-2032) Figure 18. Global Melatonin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Melatonin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Melatonin Sales Value (2021-2032) & (US$ Million) Figure 21. North America Melatonin Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Melatonin Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Melatonin Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Melatonin Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Melatonin Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Melatonin Sales Value (2021-2032) & (US$ Million) Figure 27. South America Melatonin Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Melatonin Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Melatonin Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Melatonin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Melatonin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Melatonin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Pharmaceutical Grade Melatonin
  • Food Grade Melatonin
Applications
  • Dietary Supplements
  • Medical
  • Others
Companies covered
  • Natrol
  • Pharmavite
  • Nature's Bounty
  • Jameison
  • Rexall Sundown
  • GNC
  • Xiu Zheng
  • Church & Dwight
  • By-Health
  • Pfizer
  • Solgar
  • Biotics Research
  • Now Food

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Melatonin Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Melatonin Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Melatonin Market Dynamics
  1. 2.1 Melatonin Industry Trends
  2. 2.2 Melatonin Industry Drivers
  3. 2.3 Melatonin Industry Opportunities and Challenges
  4. 2.4 Melatonin Industry Restraints
3 Melatonin Market by Company
  1. 3.1 Global Melatonin Company Revenue Ranking in 2025
  2. 3.2 Global Melatonin Revenue by Company (2021-2026)
  3. 3.3 Global Melatonin Company Ranking (2024-2026)
  4. 3.4 Global Melatonin Company Manufacturing Base and Headquarters
  5. 3.5 Global Melatonin Company Product Type and Application
  6. 3.6 Global Melatonin Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Melatonin Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Melatonin Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Melatonin Market by Type
  1. 4.1 Melatonin Type Introduction
  2. 4.1.1 Pharmaceutical Grade Melatonin
  3. 4.1.2 Food Grade Melatonin
  4. 4.2 Global Melatonin Sales Value by Type
  5. 4.2.1 Global Melatonin Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Melatonin Sales Value by Type (2021-2032)
  7. 4.2.3 Global Melatonin Sales Value Share by Type (2021-2032)
5 Melatonin Market by Application
  1. 5.1 Melatonin Application Introduction
  2. 5.1.1 Dietary Supplements
  3. 5.1.2 Medical
  4. 5.1.3 Others
  5. 5.2 Global Melatonin Sales Value by Application
  6. 5.2.1 Global Melatonin Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Melatonin Sales Value by Application (2021-2032)
  8. 5.2.3 Global Melatonin Sales Value Share by Application (2021-2032)
6 Melatonin Regional Value Analysis
  1. 6.1 Global Melatonin Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Melatonin Sales Value by Region (2021-2032)
  3. 6.2.1 Global Melatonin Sales Value by Region: 2021-2026
  4. 6.2.2 Global Melatonin Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Melatonin Sales Value (2021-2032)
  7. 6.3.2 North America Melatonin Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Melatonin Sales Value (2021-2032)
  10. 6.4.2 Europe Melatonin Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Melatonin Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Melatonin Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Melatonin Sales Value (2021-2032)
  16. 6.6.2 South America Melatonin Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Melatonin Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Melatonin Sales Value Share by Country, 2025 VS 2032
7 Melatonin Country-level Value Analysis
  1. 7.1 Global Melatonin Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Melatonin Sales Value by Country (2021-2032)
  3. 7.2.1 Global Melatonin Sales Value by Country (2021-2026)
  4. 7.2.2 Global Melatonin Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Melatonin Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Melatonin Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Melatonin Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Melatonin Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Melatonin Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Melatonin Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Melatonin Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Melatonin Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Melatonin Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Melatonin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Melatonin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Melatonin Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Melatonin Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Melatonin Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Melatonin Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Melatonin Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Melatonin Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Melatonin Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Melatonin Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Melatonin Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Melatonin Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Melatonin Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Melatonin Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Melatonin Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Melatonin Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Melatonin Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Melatonin Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Melatonin Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Melatonin Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Melatonin Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Melatonin Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Melatonin Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Melatonin Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Melatonin Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Melatonin Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Melatonin Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Melatonin Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Melatonin Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Melatonin Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Melatonin Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Melatonin Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Melatonin Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Melatonin Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Melatonin Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Melatonin Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Melatonin Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Melatonin Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Melatonin Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Melatonin Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Melatonin Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Melatonin Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Melatonin Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Melatonin Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Melatonin Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Melatonin Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Melatonin Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Melatonin Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Melatonin Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Melatonin Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Melatonin Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Melatonin Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Melatonin Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Melatonin Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Melatonin Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Melatonin Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Melatonin Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Melatonin Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Melatonin Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Melatonin Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Melatonin Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Melatonin Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Melatonin Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Melatonin Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Melatonin Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Melatonin Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Melatonin Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Melatonin Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Melatonin Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Melatonin Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Melatonin Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Melatonin Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Melatonin Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Melatonin Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Melatonin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Natrol
  2. 8.1.1 Natrol Company Information
  3. 8.1.2 Natrol Business Overview
  4. 8.1.3 Natrol Melatonin Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Natrol Melatonin Product Portfolio
  6. 8.1.5 Natrol Recent Developments
  7. 8.2 Pharmavite
  8. 8.2.1 Pharmavite Company Information
  9. 8.2.2 Pharmavite Business Overview
  10. 8.2.3 Pharmavite Melatonin Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pharmavite Melatonin Product Portfolio
  12. 8.2.5 Pharmavite Recent Developments
  13. 8.3 Nature's Bounty
  14. 8.3.1 Nature's Bounty Company Information
  15. 8.3.2 Nature's Bounty Business Overview
  16. 8.3.3 Nature's Bounty Melatonin Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nature's Bounty Melatonin Product Portfolio
  18. 8.3.5 Nature's Bounty Recent Developments
  19. 8.4 Jameison
  20. 8.4.1 Jameison Company Information
  21. 8.4.2 Jameison Business Overview
  22. 8.4.3 Jameison Melatonin Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jameison Melatonin Product Portfolio
  24. 8.4.5 Jameison Recent Developments
  25. 8.5 Rexall Sundown
  26. 8.5.1 Rexall Sundown Company Information
  27. 8.5.2 Rexall Sundown Business Overview
  28. 8.5.3 Rexall Sundown Melatonin Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Rexall Sundown Melatonin Product Portfolio
  30. 8.5.5 Rexall Sundown Recent Developments
  31. 8.6 GNC
  32. 8.6.1 GNC Company Information
  33. 8.6.2 GNC Business Overview
  34. 8.6.3 GNC Melatonin Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GNC Melatonin Product Portfolio
  36. 8.6.5 GNC Recent Developments
  37. 8.7 Xiu Zheng
  38. 8.7.1 Xiu Zheng Company Information
  39. 8.7.2 Xiu Zheng Business Overview
  40. 8.7.3 Xiu Zheng Melatonin Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Xiu Zheng Melatonin Product Portfolio
  42. 8.7.5 Xiu Zheng Recent Developments
  43. 8.8 Church & Dwight
  44. 8.8.1 Church & Dwight Company Information
  45. 8.8.2 Church & Dwight Business Overview
  46. 8.8.3 Church & Dwight Melatonin Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Church & Dwight Melatonin Product Portfolio
  48. 8.8.5 Church & Dwight Recent Developments
  49. 8.9 By-Health
  50. 8.9.1 By-Health Company Information
  51. 8.9.2 By-Health Business Overview
  52. 8.9.3 By-Health Melatonin Revenue and Gross Margin (2021-2026)
  53. 8.9.4 By-Health Melatonin Product Portfolio
  54. 8.9.5 By-Health Recent Developments
  55. 8.10 Pfizer
  56. 8.10.1 Pfizer Company Information
  57. 8.10.2 Pfizer Business Overview
  58. 8.10.3 Pfizer Melatonin Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pfizer Melatonin Product Portfolio
  60. 8.10.5 Pfizer Recent Developments
  61. 8.11 Solgar
  62. 8.11.1 Solgar Company Information
  63. 8.11.2 Solgar Business Overview
  64. 8.11.3 Solgar Melatonin Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Solgar Melatonin Product Portfolio
  66. 8.11.5 Solgar Recent Developments
  67. 8.12 Biotics Research
  68. 8.12.1 Biotics Research Company Information
  69. 8.12.2 Biotics Research Business Overview
  70. 8.12.3 Biotics Research Melatonin Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Biotics Research Melatonin Product Portfolio
  72. 8.12.5 Biotics Research Recent Developments
  73. 8.13 Now Food
  74. 8.13.1 Now Food Company Information
  75. 8.13.2 Now Food Business Overview
  76. 8.13.3 Now Food Melatonin Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Now Food Melatonin Product Portfolio
  78. 8.13.5 Now Food Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst